loadpatents
name:-0.022584915161133
name:-0.023675918579102
name:-0.098155975341797
Wilkening; Robert R. Patent Filings

Wilkening; Robert R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilkening; Robert R..The latest application filed is for "factor xi activation inhibitors".

Company Profile
3.25.26
  • Wilkening; Robert R. - Maplewood NJ
  • Wilkening, Robert R - Maplewood NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Factor Xi Activation Inhibitors
App 20220235033 - Hicks; Jacqueline D. ;   et al.
2022-07-28
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use
Grant 10,806,724 - Sebhat , et al. October 20, 2
2020-10-20
CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
App 20190247374 - Sebhat; Iyassu K. ;   et al.
2019-08-15
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2--negative allosteric modulators, compositions, and their use
Grant 10,335,399 - Sebhat , et al.
2019-07-02
Nargenicin compounds and uses thereof as antibacterial agents
Grant 10,144,741 - Young , et al. De
2018-12-04
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
Grant 10,072,003 - Arasappan , et al. September 11, 2
2018-09-11
Nargenicin Compounds And Uses Thereof As Antibacterial Agents
App 20180186808 - Young; Katherine ;   et al.
2018-07-05
Nargenicin compounds and uses thereof as antibacterial agents
Grant 9,944,654 - Young , et al. April 17, 2
2018-04-17
CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
App 20180085358 - Sebhat; Iyassu K. ;   et al.
2018-03-29
Azabenzimidazole tetrahydrofuran derivatives
Grant 9,868,733 - Apgar , et al. January 16, 2
2018-01-16
TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
App 20170305902 - Arasappan; Ashok ;   et al.
2017-10-26
Nargenicin Compounds And Uses Thereof As Antibacterial Agents
App 20170305924 - Young; Katherine ;   et al.
2017-10-26
Benzimidazole hexahydrofuro[3,2-b]furan derivatives
Grant 9,556,193 - Apgar , et al. January 31, 2
2017-01-31
Benzimidazole tetrahydrofuran derivatives
Grant 9,540,364 - Apgar , et al. January 10, 2
2017-01-10
Benzimidazole tetrahydropyran derivatives
Grant 9,527,839 - Apgar , et al. December 27, 2
2016-12-27
Azabenzimidazole tetrahydropyran derivatives
Grant 9,382,243 - Apgar , et al. July 5, 2
2016-07-05
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
Grant 9,290,517 - Apgar , et al. March 22, 2
2016-03-22
Novel Azabenzimidazole Hexahydrofuro[e,2-b]furan Derivatives
App 20150284411 - Apgar; James M. ;   et al.
2015-10-08
Novel Benzimidazole Tetrahydrofuran Derivatives
App 20150218149 - Apgar; James M. ;   et al.
2015-08-06
Novel Benzimidazole Hexahydrofuro[3,2-b]furan Derivatives
App 20150218183 - Apgar; James M. ;   et al.
2015-08-06
Novel Azabenzimidazole Tetrahydropyran Derivatives
App 20150210685 - Apgar; James M. ;   et al.
2015-07-30
Novel Azabenzimidazole Tetrahydrofuran Derivatives
App 20150203487 - Apgar; James M. ;   et al.
2015-07-23
Novel Benzimidazole Tetrahydropyran Derivatives
App 20150197516 - Apgar; James M. ;   et al.
2015-07-16
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
Grant 8,980,929 - Hicks , et al. March 17, 2
2015-03-17
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
Grant 8,853,212 - Wilkening , et al. October 7, 2
2014-10-07
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
Grant 8,796,258 - Anand , et al. August 5, 2
2014-08-05
Substituted Seven-membered Heterocyclic Compounds As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Of Diabetes
App 20130203786 - Hicks; Jacqueline D. ;   et al.
2013-08-08
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents
App 20130123237 - Anand; Rajan ;   et al.
2013-05-16
Substituted Aminotetrahydrothiopyrans And Derivatives Thereof As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Of Diabetes
App 20120277240 - Wilkening; Robert R. ;   et al.
2012-11-01
Estrogen receptor modulators
Grant 7,923,568 - Greenlee , et al. April 12, 2
2011-04-12
Estrogen Receptor Modulators
App 20100168188 - Greenlee; Mark L. ;   et al.
2010-07-01
6,11-3c-bicyclic 8a-azalide derivatives
App 20090149398 - Bartizal; Kenneth F. ;   et al.
2009-06-11
Estrogen receptor modulators
Grant 7,432,284 - Parker , et al. October 7, 2
2008-10-07
Synthesis Of 1,5-Disubstituted-2-Hydroxy-Gibbatetraen-6-Ones
App 20070293706 - Wilkening; Robert R. ;   et al.
2007-12-20
Selective estrogen receptor modulators
Grant 7,157,604 - Meng , et al. January 2, 2
2007-01-02
Estrogen receptor modulators
Grant 7,151,196 - Wilkening , et al. December 19, 2
2006-12-19
Estrogen receptor modulators
Grant 7,087,599 - Parker, Jr. , et al. August 8, 2
2006-08-08
Estrogen receptor modulators
App 20060094779 - Wilkening; Robert R. ;   et al.
2006-05-04
Estrogen receptor modulators
App 20060041003 - Parker; Dann LeRoy ;   et al.
2006-02-23
Estrogen receptor modulators
App 20050137192 - Parker, Dann R. JR. ;   et al.
2005-06-23
Selective estrogen receptor modulators
App 20040210080 - Meng, Dongfang ;   et al.
2004-10-21
Estrogen receptor modulators
App 20040127576 - Koehler, Konrad ;   et al.
2004-07-01
Estrogen receptor modulators
App 20030027840 - Parker, Dann LeRoy JR. ;   et al.
2003-02-06
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
Grant 5,985,844 - Heck , et al. November 16, 1
1999-11-16
8a-aza-8a-homoerythromycin lactams
Grant 5,202,434 - Wilkening April 13, 1
1993-04-13
8a-AZA-8a-homoerythromycin cyclic iminoethers
Grant 5,189,159 - Wilkening February 23, 1
1993-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed